Tim Mayleben

Type: Person
Name: Tim Mayleben
First reported Mar 23 2014 - Updated Mar 23 2014 - 1 reports

After positive trial, reports, Esperion plans secondary public offering

Tim Mayleben, Esperion president and CEOEsperion Therapeutics Inc. , a Plymouth Township-based early-stage pharmaceutical company, is planning a secondary public offering late this year or early next, based in part on results of a 60-patient trial it ... [Published Crains Detroit Business - Mar 23 2014]

More Content

All (1) | News (1) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
After positive trial, reports, Esperion plans s... [Published Crains Detroit Business - Mar 23 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.